asthma
one
common
chronic
syndrom
worldwid
moorman
et
al
vital
health
stat
diagnosi
clinic
syndrom
base
constel
sign
symptom
li
et
al
ann
allergi
asthma
immunol
iia
classic
symptom
asthma
includ
chest
tight
wheez
cough
dyspnea
moorman
et
al
vital
health
stat
term
asthma
encompass
spectrum
pulmonari
diseas
share
hallmark
revers
airway
obstruct
classifi
allerg
nonallerg
j
asthma
asthma
design
allerg
due
immunoglobulin
e
ige
mediat
process
note
asthma
allerg
etiolog
romanetman
et
al
allergi
differenti
diagnosi
asthma
broad
requir
detail
histori
support
pulmonari
function
test
properli
diagnos
asthma
differenti
diagnosi
pathophysiolog
introduct
word
asthma
deriv
greek
verb
aazein
mean
pant
marketo
hippocr
first
use
asthma
medic
term
refer
lung
spasm
teach
entitl
corpu
hippocraticum
marketo
ancient
china
inhal
prepar
ephedrin
contain
plant
use
stimul
betaadrenerg
receptor
within
lung
continu
mainstay
mechan
treatment
asthma
chang
et
al
dr
henri
salter
london
describ
classic
characterist
associ
asthma
airway
hyperrespons
cold
exercis
well
environment
particul
sakula
asthma
one
common
chronic
syndrom
worldwid
character
chronic
inflamm
pulmonari
airway
moorman
et
al
diagnosi
clinic
syndrom
base
constel
sign
symptom
li
et
al
classic
symptom
asthma
includ
chest
tight
wheez
cough
dyspnea
may
resolv
spontan
respons
treatment
moorman
et
al
tabl
definit
criteria
diagnosi
asthma
exist
li
et
al
term
asthma
encompass
spectrum
pulmonari
diseas
share
hallmark
revers
airway
obstruct
classifi
allerg
nonallerg
asthma
result
igemedi
immunolog
mechan
design
allerg
associ
ige
classifi
nonallerg
consist
mani
phenotyp
romanetman
et
al
pathophysiolog
asthma
character
revers
airway
obstruct
nonspecif
airway
hyperreact
chronic
inflamm
kudo
et
al
recurr
airflow
limit
driven
inflammatori
mediat
lead
bronchoconstrict
airway
edema
hyperrespons
airway
remodel
bronchoconstrict
result
bronchial
smooth
muscl
contract
immedi
respons
inhal
irrit
allergen
nation
classic
complet
revers
airway
obstruct
indic
asthma
mani
case
asthma
may
partial
revers
airflow
case
revers
obstruct
fix
airway
obstruct
may
part
due
airway
remodel
investig
still
underway
understand
exact
pathophysiolog
howev
upregul
growth
factor
bronchial
epithelium
seem
key
persist
inflamm
smooth
muscl
hypertrophi
collagen
product
neovascular
basement
membran
thicken
increas
myofibroblast
fibroblast
activ
buss
et
al
allerg
asthma
activ
mast
cell
helper
cell
inhal
antigen
lead
product
secret
histamin
leukotrien
cytokin
nation
key
cytokin
cascad
includ
latter
primari
signal
differenti
eosinophil
eosinophil
prolong
potenti
persist
airway
inflamm
releas
leukotrien
granul
protein
gmcsf
consist
postmortem
histopatholog
show
eosinophil
infiltr
mucosa
airway
mucou
plug
airway
lumen
buss
et
al
classif
asthma
sever
mild
moder
sever
consist
histopatholog
chang
proxim
distal
airway
epitheli
detach
goblet
cell
hyperplasia
subepitheli
fibrosi
infiltr
inflammatori
mediat
bronchial
smooth
muscl
hypertrophi
vascular
chang
observ
hamid
despit
consist
chang
cours
asthma
variabl
sever
progress
individu
life
individu
major
patient
asthma
begin
earli
life
risk
factor
develop
includ
atop
diseas
recurr
wheez
parent
histori
asthma
common
asthma
trigger
environment
factor
air
pollut
tobacco
smoke
occup
exposur
indoor
allergen
dust
mite
mold
pet
rodent
cockroach
outdoor
allergen
tree
grass
weed
pollen
exercis
infect
cdc
yang
et
al
tabl
viral
infect
airborn
allergen
two
import
environment
factor
lead
asthma
develop
persist
possibl
asthma
sever
nhlbi
though
allergen
environment
factor
strong
trigger
mani
asthma
complet
avoid
often
imposs
despit
avoid
asthma
often
remain
activ
respond
avoid
treatment
base
symptom
frequenc
sever
diseas
quick
relief
medic
inhal
shortact
anticholinerg
longterm
control
medic
use
treat
persist
asthma
includ
inhal
longact
anticholinerg
corticosteroid
cromolyn
sodium
oral
leukotrien
modifi
methylxanthin
fail
respond
convent
therapi
note
may
respond
biolog
agent
depend
phenotyp
classif
asthma
aaaai
allergen
foreman
et
al
diagnosi
aco
clinic
key
symptom
share
pure
copd
asthma
add
challeng
accur
make
diagnosi
saetta
et
al
barn
fig
copd
consid
less
revers
obstruct
airway
diseas
howev
copd
revers
even
degre
asthma
symptom
experienc
patient
copd
common
asthma
well
includ
wheez
cough
dyspnea
diseas
diagnos
similarli
take
account
patient
histori
well
pulmonari
function
test
pft
chronic
obstruct
lung
diseas
defin
forc
expiratori
volum
forc
vital
capac
fvc
ratio
less
revers
albuterol
alpert
et
al
characterist
distinguish
copd
asthma
includ
failur
revers
normal
therapi
strong
associ
cigarett
smoke
inhal
smoke
indoor
burn
organ
materi
cook
reduc
diffus
capac
lung
carbon
monoxid
dlco
stoller
et
al
cigarett
smoke
exposur
dosedepend
make
import
determin
smoker
total
packyear
number
cigarett
pack
smoke
per
day
multipli
number
year
individu
smoke
mont
de
oca
et
al
secondhand
cigarett
exposur
risk
factor
well
recent
gain
signific
recognit
role
develop
copd
guerra
et
al
emphysema
increas
dead
space
ventil
destroy
alveolar
membran
lead
imbal
amount
inhal
air
rel
surfac
area
lung
capabl
ga
exchang
miravitl
et
al
emphysema
may
ascertain
use
ct
scan
chest
demonstr
classic
copd
find
emphysema
vast
destruct
dilat
alveoli
comparison
asthma
alveoli
destroy
instead
air
trap
within
alveoli
due
bronchial
obstruct
result
asthma
decreas
ventil
surfac
area
capabl
ga
exchang
remain
intact
normal
dlco
miravitl
et
al
asthma
patient
given
diagnosi
asthma
refractori
treatment
evalu
altern
diagnosi
aguilar
et
al
tabl
acut
respiratori
symptom
tachypnea
fever
radiolog
evid
parenchym
infiltr
defin
pneumonia
pneumonia
often
initi
colon
nasopharynx
subsequ
infect
lower
respiratori
tract
caus
bacteria
virus
fungi
brown
tabl
viral
etiolog
main
trigger
asthma
exacerb
respiratori
virus
etiolog
agent
nearli
patient
present
pneumonia
johnston
et
al
viral
caus
pneumonia
includ
influenza
viru
especi
influenza
outbreak
musher
import
maintain
high
index
suspicion
secondari
bacteri
infect
patient
well
respiratori
syncyti
viru
parainfluenza
viru
human
metapneumoviru
adenoviru
coronaviru
rhinoviru
also
detect
patient
commun
acquir
pneumonia
cap
musher
children
respiratori
virus
common
caus
pneumonia
jain
et
al
syndrom
suggest
viral
etiolog
usual
treat
symptomat
measur
symptom
suggest
influenza
culprit
oseltamivir
viral
neuraminidas
inhibitor
administ
within
first
h
symptom
musher
patient
develop
acut
lung
infect
recent
hospit
also
routin
exposur
healthcar
system
fall
categori
communityacquir
pneumonia
cap
musher
common
bacteri
caus
cap
streptococcu
pneumonia
common
haemophilu
influenza
staphylococcu
aureu
musher
mycoplasma
pneumonia
atyp
speci
also
implic
occur
earlyand
lateonset
asthma
yeh
et
al
compar
typic
bacteri
pneumonia
atyp
pneumonia
usual
present
less
sever
symptom
headach
malais
low
grade
fever
gradual
onset
brown
mainstay
therapi
bacteri
pneumonia
administr
antimicrobi
agent
appropri
overal
clinic
condit
patient
suspect
microorgan
question
uncommon
caus
cap
present
subacut
infect
due
fungal
etiolog
histoplasma
coccidioid
speci
endem
area
type
infect
character
cough
fever
pulmonari
infiltr
treat
appropri
antifung
therapi
musher
candida
aspergillu
zygomycet
main
fungal
isol
obtain
respiratori
secret
icu
patient
shamim
et
al
commonli
occur
neutropenia
nonneutropen
patient
appropri
risk
factor
intens
care
unit
develop
type
patholog
treat
appropri
antifung
therapi
determin
identifi
microorgan
shamim
et
al
gastroesophag
reflux
diseas
gerd
classic
present
symptom
persist
heartburn
metal
tast
nih
howev
either
symptom
present
time
extraesophag
symptom
may
includ
chronic
cough
wheez
bronchospasm
sore
throat
laryng
hoars
nih
badillo
symptom
gerd
may
trigger
select
number
food
drink
coffe
chocol
citru
fruit
tomatobas
food
spici
food
fatti
food
alcohol
gerd
present
sever
differ
way
time
resembl
asthma
suggest
extraesophag
manifest
asthmat
reflux
serv
potenti
trigger
contribut
factor
asthma
hard
gold
standard
diagnosi
gerd
upper
endoscopi
show
characterist
esophag
chang
case
nwokediuko
gerd
may
differenti
asthma
ph
probe
andor
barium
swallow
king
howev
definit
test
reliabl
confirm
diagnosi
gerd
gerd
coexist
asthma
patient
sontag
treatment
gerd
pursu
patient
symptomat
although
appear
gerd
worsen
asthma
nejm
thu
diagnosi
made
predominantli
clinic
suspicion
combin
medic
trial
patient
signific
asthma
symptom
improv
proton
pump
inhibitor
therapi
like
gerd
gerd
treatment
ineffect
persist
asthma
without
gerd
symptom
nejm
asthma
consid
extraesophag
symptom
cough
wheez
bronchospasm
persist
despit
maxim
gerd
treatment
sinus
essenti
differenti
asthma
sinus
exhibit
respiratori
symptom
similar
asthma
short
breath
extens
turbin
edema
cough
postnas
drip
bucca
et
al
addit
condit
share
mani
inflammatori
mediat
may
trigger
infect
air
pollut
allergen
allerg
subject
frieri
preval
sinus
popul
unit
state
moss
symptom
includ
nasal
congest
sinu
discharg
facial
pressur
diminish
sens
smell
wald
et
al
addit
symptom
formal
diagnosi
patient
must
evid
sinu
inflamm
demonstr
either
endoscopi
computer
tomographi
ct
scan
wald
et
al
sinus
term
chronic
symptom
present
week
longer
wald
et
al
chronic
sinus
often
longer
durat
diminish
sever
symptom
compar
acut
sinus
wald
et
al
varieti
etiolog
contribut
syndrom
chronic
sinus
allerg
rhinosinus
due
perenni
allergen
rel
common
associ
sneez
itch
william
continu
exposur
perenni
allergen
dust
mite
anim
dander
mold
cockroach
contribut
chronic
diseas
william
intranas
corticosteroid
treatment
choic
allerg
rhiniti
ratner
et
al
common
isol
bacteri
sinus
includ
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
zimmerman
amoxicillin
without
clavulan
firstlin
therapi
bacteri
sinus
lund
recurr
episod
bacteri
sinus
prompt
evalu
immunolog
anatom
abnorm
zimmerman
congest
heart
failur
chf
due
varieti
etiolog
result
systol
diastol
ventricular
dysfunct
figueroa
diagnosi
base
thorough
histori
physic
exam
support
appropri
ancillari
test
echocardiogram
electrocardiogram
chest
xray
figueroa
chf
lead
caus
acut
dyspnea
elderli
patient
onethird
affect
experi
cardiac
wheez
could
confus
asthma
jorg
et
al
nonelderli
patient
rate
wheez
patient
chf
basi
statist
chf
consid
differenti
diagnosi
patient
dyspnea
wheez
underli
pathophysiolog
mechan
cardiac
wheez
seem
aris
left
ventricular
lv
dysfunct
lv
function
deterior
increas
pulmonari
vascular
pressur
caus
leakag
plasma
interstiti
space
dominguez
interstiti
pressur
rise
result
narrow
bronchiol
return
caus
imped
conduct
air
result
wheez
sound
dominguez
diures
subject
presum
improv
clinic
pictur
reduc
extravascular
lung
water
overal
gener
improv
pulmonari
bronchial
lung
volum
jorg
et
al
diagnosi
chf
made
treatment
compris
pharmacolog
nonpharmacolog
measur
pharmacolog
treatment
combin
use
afterload
reduct
angiotensinconvert
enzym
inhibitor
reduct
catecholamin
surg
betablock
preload
reduct
diuret
relief
dyspnea
sign
water
sodium
retent
figueroa
nonpharmacolog
treatment
includ
ventricular
synchron
via
biventricular
pace
devic
well
implant
defibril
import
key
determin
appropri
treatment
patient
chf
clinic
stratifi
appropri
new
york
heart
associ
classif
system
system
provid
yardstick
comparison
chf
treatment
figueroa
vocal
cord
dysfunct
vcd
occur
vocal
cord
open
properli
close
inappropri
particularli
inspir
specif
inappropri
adduct
vocal
cord
usual
inhal
caus
vocal
cord
hyperrespons
symptom
resembl
asthma
two
diagnos
confus
lead
misdiagnosi
inappropri
treatment
persist
uncontrol
respiratori
symptom
dunn
aaaai
clinic
present
vocal
cord
dysfunct
vari
asymptomat
mild
dyspnea
symptom
suggest
acut
asthma
exacerb
maillard
et
al
symptom
wheez
hoars
voic
difficulti
breath
cough
dysphagia
throat
tight
globu
sensat
chest
pain
occur
similar
asthma
vcd
trigger
temperatur
chang
upper
respiratori
infect
emot
stressor
physic
exert
exercis
acid
reflux
ingest
specif
food
laugh
talk
sing
strong
odor
inhal
respiratori
irrit
andrianopoulo
et
al
morrison
et
al
featur
may
distinguish
vcd
asthma
inspiratori
wheez
trigger
odor
dysphonia
throat
tight
absolut
distinguish
featur
vcd
asthma
two
disord
coexist
aaaai
diagnosi
vcd
begin
thorough
clinic
histori
physic
exam
assess
characterist
featur
often
patient
point
throat
ask
symptom
origin
vocal
cord
dysfunct
questionnair
vcdq
questionnair
develop
fowler
colleagu
may
help
assess
sever
symptom
improv
instrument
demonstr
improv
score
follow
speech
therapi
fowler
et
al
pittsburgh
vcd
index
anoth
tool
develop
traister
colleagu
help
distinguish
vcd
asthma
score
assign
base
symptom
throat
tight
score
dysphonia
score
absenc
wheez
score
presenc
odor
trigger
score
score
sensit
specif
diagnosi
vcd
traister
et
al
spirometri
may
help
differenti
vcd
asthma
flatten
sawtooth
pattern
andor
truncat
may
seen
inspiratori
flow
loop
indic
variabl
extrathorac
obstruct
balkissoon
miller
characterist
may
occur
patient
asymptomat
like
acut
vcd
attack
balkissoon
laryngoscopi
show
paradox
vocal
fold
movement
inhal
gold
standard
diagnosi
vcd
although
attack
vocal
cord
may
normal
condit
exclud
normal
examin
symptom
minim
absent
sever
case
airway
becom
compromis
small
starshap
orific
often
term
chink
may
avail
inhal
lead
acut
respiratori
distress
treatment
vcd
focus
patient
reassur
benign
natur
condit
speech
therapi
deep
breath
techniqu
may
reduc
laryng
hyperreact
inappropri
highdos
inhal
therapi
particularli
corticosteroid
may
contribut
condit
irrit
larynx
result
revers
laryngomalacia
anaphylaxi
system
potenti
lifethreaten
immedi
reaction
commonli
induc
allergi
medic
food
classic
result
igemedi
mechan
may
affect
cutan
respiratori
cardiovascular
gastrointestin
system
anaphylact
event
resembl
asthma
respiratori
symptom
preced
organ
system
manifest
approxim
anaphylact
reaction
present
respiratori
manifest
short
breath
wheez
nasal
congest
therefor
import
perform
thorough
physic
examin
well
obtain
adequ
histori
distinguish
multisystem
lifethreaten
reaction
acut
asthmat
attack
subject
asthma
risk
sever
anaphylaxi
particularli
asthma
well
control
time
anaphylaxi
exerciseinduc
anaphylaxi
eia
may
misdiagnos
exerciseinduc
asthma
trigger
exerciseinduc
may
obviou
sinc
inconsist
reproduc
eia
occur
patient
engag
rigor
physic
activ
symptom
progress
durat
activ
subset
eia
fooddepend
major
eia
episod
nonfooddepend
fooddepend
eia
trigger
elus
sinc
patient
must
exercis
within
h
ingest
specif
food
initi
symptom
may
includ
wheez
dyspnea
although
manifest
may
soon
follow
includ
pruritu
urticaria
dizzi
manifest
hypotens
accur
histori
event
reaction
necessari
differenti
eia
exerciseinduc
asthma
idiopath
anaphylaxi
differenti
diagnosi
patient
suspect
asthma
condit
present
acut
onset
dyspnea
wheez
cough
anxieti
sens
impend
doom
simon
et
al
classic
anaphylaxi
refer
system
igemedi
hypersensit
reaction
due
releas
mediat
basophil
mast
cell
johansson
et
al
anaphylaxi
clinic
diagnosi
requir
specif
test
confirm
identif
specificig
culprit
caus
necessari
establish
allerg
anaphylaxi
bacal
et
al
term
idiopath
anaphylaxi
refer
absenc
identifi
trigger
account
often
multipl
system
reaction
kemp
et
al
may
caus
clinician
overlook
anaphylaxi
etiolog
patient
symptom
sinc
histori
exposur
typic
allergen
report
idiopath
anaphylaxi
diagnosi
exclus
true
idiopath
disord
exact
incid
unknown
estim
affect
individu
annual
unit
state
patterson
et
al
common
among
adult
children
women
men
approxim
subject
idiopath
anaphylaxi
atop
patterson
et
al
definit
subject
idiopath
anaphylaxi
identifi
caus
anaphylact
reaction
eventu
exercis
certain
food
identifi
trigger
case
respect
ditto
et
al
organ
system
diseas
involv
mast
cell
must
consid
well
instanc
initi
diagnos
idiopath
anaphylaxi
ultim
found
system
mastocytosi
akin
et
al
manag
idiopath
versu
nonidiopath
anaphylaxi
significantli
differ
goal
prevent
futur
reaction
occur
medic
manag
idiopath
anaphylaxi
oppos
avoid
known
trigger
nonidiopath
anaphylaxi
blatman
et
al
patient
treat
prophylact
antagonist
longterm
control
rare
case
addit
system
corticosteroid
blatman
et
al
wong
et
al
patient
also
prescrib
epinephrin
autoinjector
effect
treatment
anaphylaxi
preliminari
data
use
omalizumab
antiig
monoclon
antibodi
promis
warrier
et
al
success
use
rituximab
monoclon
antibodi
specif
b
lymphocyt
induc
remiss
also
report
borzutzki
et
al
aspirinexacerb
respiratori
diseas
aerd
often
refer
samter
triad
triad
includ
asthma
sinu
diseas
recurr
nasal
polyposi
sensit
aspirin
nonsteroid
antiinflammatori
drug
nsaid
pongde
hallmark
chronic
medic
condit
exacerb
upper
andor
lower
airway
diseas
follow
ingest
aspirin
nsaid
aguilar
et
al
reaction
may
includ
nasal
congest
frontal
headach
sinu
pressur
cough
wheez
chest
tight
less
commonli
skin
flush
rash
abdomin
pain
vomit
pongde
predomin
respiratori
symptom
wheez
chest
tight
expert
consid
aerd
phenotyp
asthma
rather
separ
diagnosi
epidemiolog
asthmat
patient
asthma
concurr
nasal
polyp
aerd
pongde
patient
condit
commonli
develop
symptom
adulthood
age
year
pongde
aguilar
et
al
usual
patient
present
adult
onset
asthma
preced
year
sinonas
symptom
aguilar
et
al
primari
mediat
aerd
inflamm
arachidon
acid
pathway
arachidon
acid
metabol
either
cyclooxygenas
yield
prostaglandin
lipoxygenas
yield
proinflammatori
cysteinyl
leukotrien
significantli
overproduc
patient
aerd
aguilar
et
al
laidlaw
rel
excess
cysteinyl
leukotrien
lead
shift
toward
proinflammatori
state
laidlaw
moebu
inhibit
may
explan
rapid
deterior
ingest
nsaid
diagnosi
aerd
confirm
oral
aspirin
challeng
may
treat
aspirin
desensit
involv
dose
escal
therapeut
rang
mg
bid
continu
daili
aguilar
et
al
goal
desensit
control
upper
lower
respiratori
symptom
reduc
use
system
corticosteroid
decreas
rate
growth
recurr
nasal
polyp
improv
patient
qualiti
life
moebu
continu
aspirin
therapi
decreas
bronchial
hyperreact
improv
nasal
symptom
addit
reduc
polyp
growth
asthmat
patient
respond
tradit
asthma
therapi
difficult
control
evalu
aerd
aguilar
et
al
patient
experi
sever
exacerb
often
requir
control
inhal
corticosteroid
leukotrien
modifi
drug
well
aspirin
desensit
aguilar
et
al
moebu
malign
may
resembl
asthma
case
mask
underli
diagnosi
import
consid
malign
differenti
diagnosi
patient
persist
respiratori
symptom
despit
adequ
asthma
therapi
lung
cancer
account
million
death
worldwid
lung
parenchyma
limit
sensori
innerv
primari
lung
cancer
may
reach
consider
size
becom
symptomat
gani
et
al
common
earli
symptom
cough
occur
due
bronchial
irrit
obstruct
patient
dyspnea
occur
approxim
patient
earli
symptom
hemoptysi
result
ulcer
bronchial
tissu
tumor
invas
tumor
necrosi
earli
symptom
patient
wheez
occur
lung
cancer
patient
due
partial
bronchial
obstruct
usual
hilar
tumor
gani
et
al
carcinoid
tumor
rare
occur
per
slow
grow
may
either
benign
malign
crocetti
pulmonari
carcinoid
tumor
compromis
lung
cancer
commonli
locat
central
main
lobar
bronchi
hage
et
al
filosso
et
al
symptom
pulmonari
carcinoid
tumor
includ
hemoptysi
cough
wheez
dyspnea
lower
respiratori
tract
infect
schreven
et
al
zuetenhorst
typic
delay
onset
symptom
time
diagnosi
patient
often
misdiagnos
asthma
walusiak
dipaolo
wynn
et
al
diffus
idiopath
pulmonari
neuroendocrin
hyperplasia
dipnech
classifi
premalign
condit
caus
wheez
cough
dyspnea
rel
poor
respons
inhal
therapi
improv
system
corticosteroid
thu
premalign
lung
condit
may
confus
asthma
octreotid
somatostatin
analog
reduc
symptom
pulmonari
sarcoidosi
differenti
diagnosi
suspect
asthma
sarcoidosi
present
dyspnea
cough
therebi
mimick
asthma
ungprasert
sarcoidosi
noncas
granulomat
diseas
involv
multipl
organ
system
iannuzzi
et
al
thoma
annual
incid
rate
sarcoidosi
per
among
africanamerican
versu
per
among
caucasian
thoma
ungprasert
ungprasert
et
al
ninetyseven
percent
evid
intrathorac
sarcoidosi
respiratori
symptom
ungprasert
et
al
definit
diagnost
test
exist
sarcoidosi
diagnosi
exclus
depend
clinic
radiograph
histopatholog
find
consist
diseas
judson
pathogenesi
sarcoidosi
extens
studi
howev
incit
etiolog
stimulu
establish
iannuzzi
et
al
thoma
major
sarcoidosi
patient
pulmonari
involv
account
major
morbid
mortal
iannuzzi
et
al
thoma
initi
pulmonari
lesion
compris
cell
subsequ
develop
classic
noncas
granuloma
characterist
sarcoidosi
tazi
et
al
lecossi
et
al
mani
patient
sarcoidosi
requir
treatment
iannuzzi
et
al
patient
sever
pulmonari
diseas
treat
reduc
granulomat
inflamm
develop
irrevers
lung
damag
iannuzzi
et
al
glucocorticoid
use
initi
therapi
presenc
mycobacterium
tuberculosi
exclud
baughman
et
al
prednison
mainten
dose
mgkg
may
prevent
progress
diseas
baughman
expert
recommend
minimum
month
therapi
prevent
relaps
wijsenbeek
patient
respond
glucocorticoid
therapi
patient
respond
glucocorticoid
requir
altern
immunosuppress
agent
baughman
altern
agent
consid
sarcoidosi
progress
despit
adequ
glucocorticoid
therapi
patient
toler
refus
glucocorticoid
sharma
methotrex
commonli
use
altern
avoid
liver
diseas
du
boi
immunosuppress
agent
azathioprin
leflunomid
tnfalpha
antagonist
consid
option
du
boi
hypersensit
pneumon
hp
respiratori
syndrom
differenti
diagnosi
asthma
clinic
overlap
asthma
due
great
variabl
symptom
sever
clinic
present
variou
stage
diseas
hypersensit
pneumon
also
known
extrins
allerg
alveol
result
inflammatori
respons
repeat
exposur
varieti
antigen
particl
environ
particl
affect
lung
parenchyma
specif
alveoli
termin
bronchiol
alveolar
interstitium
sforza
ohshimo
et
al
dispers
antigen
must
size
appropri
reach
alveolar
space
less
selman
antigen
includ
mammalian
avian
protein
fungi
thermophil
bacteria
chemic
compound
combin
host
protein
form
hapten
selman
antigen
caus
trigger
asthma
add
difficulti
distinguish
two
diseas
clinic
present
hp
classifi
acut
subacut
chronic
stage
ohshimo
et
al
acut
form
present
flulik
prodrom
includ
fever
chill
malais
concomit
respiratori
featur
cough
dyspnea
chest
tight
tachypnea
symptom
usual
present
h
exposur
antigen
ohshimo
et
al
acut
diseas
stage
nonprogress
improv
antigen
avoid
howev
recur
follow
reintroduct
etiolog
antigen
ohshimo
et
al
subacut
form
usual
result
continu
lowlevel
exposur
antigen
usual
result
progress
undiagnos
acut
hp
selman
clinic
find
includ
dyspnea
product
cough
progress
week
subacut
stage
fatigu
anorexia
weight
loss
also
common
selman
chronic
hp
may
result
continu
low
level
exposur
inhal
antigen
either
unrecogn
acut
subacut
episod
known
recurr
chronic
hp
insidi
chronic
hp
would
describ
patient
without
previou
histori
acut
hp
patient
experi
progress
dyspnea
exert
cough
fatigu
malais
weight
loss
condit
often
progress
diffus
fibrosi
endstag
lung
diseas
pathophysiolog
diseas
process
clearli
understood
howev
seem
due
humor
cellular
mechan
selman
acut
phase
inflamm
due
immun
complexmedi
reaction
high
titer
antigenspecif
serum
immunoglobulin
g
term
precipitin
elev
neutrophil
subacut
chronic
hp
amplifi
tcellmedi
immun
respons
selman
migrat
prolifer
decreas
apoptosi
lymphocyt
contribut
pathogenesi
classic
tlymphocyt
alveol
hp
classic
understood
diseas
ohshimo
et
al
howev
evolv
fibrosi
seen
chronic
form
hp
may
driven
mechan
understand
mechan
hp
evolv
studi
need
explain
diseas
develop
minor
expos
individu
ohshimo
et
al
diagnosi
hp
reli
thorough
histori
physic
examin
particular
attent
environment
occup
histori
sforza
ohshimo
et
al
sever
diagnost
criteria
propos
none
valid
therefor
high
level
clinic
suspicion
recognit
inhal
antigen
exposur
relev
clinic
investig
includ
imag
laboratori
patholog
find
help
confirm
diagnosi
hp
ohshimo
et
al
symptom
pulmonari
arteri
hypertens
pah
misinterpret
asthma
symptom
pah
includ
breathless
dyspnea
exert
cardiac
palpit
fatigu
syncop
chest
discomfort
pah
incur
progress
diseas
character
elev
pulmonari
arteri
pressur
lead
right
ventricular
failur
chin
person
histori
heart
diseas
congenit
heart
defect
scleroderma
hiv
famili
histori
assess
may
contribut
pah
physic
examin
may
show
sign
right
heart
failur
lower
extrem
edema
promin
jugular
vein
echocardiogram
use
screen
tool
assess
ventricular
function
right
ventricular
catheter
remain
gold
standard
diagnosi
rich
hemodynam
diagnost
criteria
pah
includ
mean
pulmonari
arteri
pressur
mmhg
pulmonari
capillari
wedg
left
ventricular
enddiastol
pressur
mm
hg
pulmonari
vascular
resist
wood
unit
chin
lymphangioleiomyomatosi
progress
rare
cystic
lung
diseas
predominantli
affect
young
women
reproduct
age
pai
respiratori
find
common
diseas
process
differenti
diagnosi
asthma
especi
premenopaus
femal
lam
consid
patient
dyspnea
cough
chest
pain
johnson
et
al
zhou
et
al
lam
often
mimic
copd
asthma
bronchiti
may
lead
delay
diagnosi
natur
cours
diseas
usual
vari
affect
women
high
risk
develop
pneumothorax
rapid
declin
lung
function
progress
respiratori
failur
death
taylor
johnson
et
al
lung
lesion
lam
identifi
chest
ct
appear
numer
scatter
thinwal
cyst
evenli
distribut
throughout
lung
field
johnson
et
al
histolog
lung
lesion
small
cluster
prolifer
smooth
musclelik
cell
distribut
along
peripher
vessel
bronchiol
lymphat
taylor
et
al
due
chang
conduct
airway
compress
obstruct
caus
clinic
respiratori
find
describ
diagnos
lam
thorough
histori
physic
examin
combin
find
angiolipoma
lymphat
diseas
chest
ct
serum
vegfd
test
may
help
lung
biopsi
may
employ
clinic
inform
inconclus
johnson
et
al
zhou
et
al
diagnosi
made
patient
undergo
complet
pulmonari
function
test
receiv
pneumococc
influenza
vaccin
pulmonari
rehab
appropri
drug
treatment
bronchodil
obstruct
symptom
present
johnson
et
al
zhou
et
al
taylor
et
al
patient
also
made
awar
potenti
risk
associ
role
estrogen
diseas
take
appropri
precaut
term
estrogen
contain
pharmacotherapi
johnson
et
al
taylor
et
al
diagnosi
lam
establish
patient
manag
close
pulmonari
team
made
awar
chronic
diseas
johnson
et
al
cystic
fibrosi
mimic
asthma
due
cough
dyspnea
similar
asthma
autosom
recess
disord
current
peopl
unit
state
live
cystic
fibrosi
approxim
new
case
diagnos
year
patient
diagnos
disord
age
year
newborn
screen
program
cystic
fibrosi
news
today
cystic
fibrosi
caus
mutat
cystic
fibrosi
transmembran
conduct
regul
cftr
gene
gene
regul
anion
transport
mucociliari
clearanc
airway
due
dysfunct
cftr
gene
mucou
retent
lead
chronic
infect
local
airway
inflamm
often
result
progress
lung
damag
decreas
life
expect
elborn
et
al
symptom
includ
salti
tast
skin
persist
cough
product
thick
mucu
wheez
dyspnea
frequent
sinus
bronchiti
pneumonia
digest
problem
includ
malabsorpt
failur
gain
weight
nih
newborn
unit
state
screen
cystic
fibrosi
via
genet
test
blood
test
test
suggest
cystic
fibrosi
diagnosi
confirm
sweat
test
goal
treatment
focu
decreas
infect
pulmonari
hygien
optim
digest
health
pulmonari
eosinophilia
encompass
group
heterogen
diseas
diseas
must
consid
differenti
asthma
sinc
may
present
dyspnea
wheez
cough
loffler
eosinophil
lung
diseas
may
character
peripher
eosinophilia
support
pulmonari
radiograph
find
eosinophil
demonstr
lung
biopsi
increas
eosinophil
bronchoalveolar
lavag
bal
allen
bain
peripher
eosinophilia
absolut
eosinophil
count
cell
per
microlit
greater
support
eosinophil
pulmonari
diseas
valent
et
al
degre
eosinophilia
enabl
diagnos
precis
etiolog
umeki
et
al
highresolut
ct
scan
chest
provid
signific
find
earli
cours
diseas
johkoh
et
al
syndrom
one
mani
diseas
classifi
eosinophil
pulmonari
diseas
occur
helminth
larva
migrat
lung
infect
individu
matur
ascend
airway
return
gastrointestin
tract
wilson
four
type
helminth
life
cycl
within
lung
ascari
lumbricoid
ancylostoma
duodenal
necat
americanu
strongyloid
stercorali
wilson
syndrom
origin
describ
patient
present
fleet
pulmonari
opac
peripher
eosinophilia
expos
soil
contamin
human
wast
chronic
eosinophil
pneumonia
cep
character
increas
pulmonari
eosinophil
jederlin
et
al
idiopath
diseas
occur
predominantli
nonsmok
women
marchand
et
al
symptom
weight
loss
night
sweat
may
occur
addit
respiratori
symptom
laboratori
find
mimic
asthma
addit
mimick
asthma
case
cep
concurr
histor
diagnosi
asthma
jederlin
peripher
eosinophilia
typic
featur
present
case
marchand
et
al
virtual
pathognomon
find
chest
xray
peripher
pulmonari
infiltr
describ
photograph
neg
pulmonari
edema
may
observ
onethird
cep
case
jederlin
clinic
diagnosi
cep
base
combin
peripher
bal
eosinophilia
subacut
present
characterist
radiograph
find
jederlin
cep
treat
corticosteroid
churgstrauss
syndrom
css
also
known
eosinophil
granulomatosi
polyangi
rare
granulomat
eosinophil
vascul
character
diffus
necrot
vascul
extravascular
granuloma
seen
almost
exclus
patient
asthma
tissu
eosinophilia
greco
et
al
treat
difficult
control
asthma
corticosteroid
mask
diagnosi
given
increas
mortal
delay
diagnosi
activ
vascul
phase
clinician
keep
diagnosi
churgstrauss
differenti
diagnosi
asthma
dcruz
aguilar
churgstrauss
classic
follow
triphas
pattern
first
phase
initi
prodrom
consist
upper
airway
diseas
rhinosinus
asthma
second
phase
eosinophil
phase
character
signific
peripher
eosinophilia
myocardi
pulmonari
gastrointestin
involv
final
phase
vascul
phase
phase
progress
diseas
multisystem
small
vessel
vascul
greco
et
al
dcruz
et
al
aguilar
et
al
patient
css
typic
present
dyspnea
cough
wheez
refractori
tradit
asthma
treatment
peripher
manifest
vascul
subject
histori
asthma
diagnosi
css
reli
radiolog
laboratori
patholog
find
css
small
vessel
vascul
associ
perinuclearantineutrophil
cytoplasm
antibodi
panca
approxim
patient
antigen
recogn
autoantibodi
usual
myeloperoxidas
mpo
absenc
anca
exclud
diagnosi
greco
et
al
aguilar
et
al
four
follow
criteria
aid
diagnosi
css
presenc
asthma
greater
peripher
eosinophilia
mononeuropathi
multiplex
polyneuropathi
nonfix
lung
infiltr
sinu
abnorm
extravascular
eosinophil
tissu
biopsi
particularli
blood
vessel
wall
perivascular
local
aguilar
et
al
author
suggest
patient
asthma
concurr
featur
multisystem
diseas
consid
underli
vascul
css
dcruz
et
al
triad
wegen
granulomatosi
granulomatosi
polyangi
gpa
consist
necrot
granulomat
inflamm
upper
lower
airway
necrot
glomerulonephr
autoimmun
necrot
vascul
lamprecht
gpa
vascul
affect
mediumand
smallsiz
vessel
gpa
usual
present
middl
age
occur
older
adult
rare
childhood
diseas
affect
almost
site
bodi
howev
classic
site
involv
includ
upper
respiratori
tract
lung
kidney
patient
may
present
multitud
complaint
fever
fatigu
unintent
weight
loss
hear
chang
recurr
sinus
persist
rhinorrhea
eye
problem
nasal
crust
ulcer
epistaxi
caus
local
inflamm
dyspnea
hoars
caus
subglott
stenosi
cough
bloodi
sputum
wheez
caus
upper
lower
airway
inflamm
joint
pain
hematuria
diagnosi
may
delay
month
earli
clinic
symptom
gpa
similar
milder
common
respiratori
problem
combin
canca
cytoplasmicanca
antiproteinas
pancaantimpo
high
specif
diagnosi
gpa
diagnosi
gpa
confirm
biopsi
tissu
upper
respiratori
tract
obtain
less
risk
howev
yield
upper
airway
biopsi
rel
low
lung
biopsi
renal
biopsi
kidney
involv
suspect
often
best
way
diagnos
disord
treatment
focus
longterm
immunosuppress
microscop
polyangi
anoth
system
vascul
pulmonari
involv
gener
manifest
dyspnea
cough
gener
alveol
alveolar
hemorrhag
ct
scan
usual
demonstr
groundglass
chang
rather
nodul
typic
gpa
microscop
polyangi
usual
anca
posit
although
reliabl
gpa
eosinophilia
typic
microscop
polyangi
associ
specif
asthma
vasculit
syndrom
diagnosi
requir
tissu
biopsi
demonstr
small
arteri
arteriol
damag
hemorrhag
although
asthma
common
diseas
state
mimic
asthma
emphas
chapter
cardin
symptom
asthma
cough
short
breath
wheez
chest
tight
share
mani
disord
confus
asthma
may
complic
asthma
care
attent
histori
well
physic
examin
select
imag
spirometri
andor
laboratori
facilit
appropri
classif
diagnosi
subject
suspect
asthma
corticosteroid
therapi
typic
use
asthma
may
improv
mani
condit
differenti
diagnosi
clinic
vigil
essenti
particularli
clinic
cours
atyp
asthma
fail
resolv
appropri
asthma
therapi
